CAPR — CAPRICOR THERAPEUTICS INC

Ownership history in XTX Topco Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in CAPRICOR THERAPEUTICS INC (CAPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2025 Q1)
Avg. % of fund
0.01%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 14,442 -13,057 -47.5% 0.01% $104K $7.21
2025 Q2 REDUCED 27,499 -27,371 -49.9% 0.01% $273K $9.93
2025 Q1 INITIATED 54,870 — — 0.03% $521K $9.49
% of Fund (quarterly)    CAPR price (monthly, adj. close)

Other funds also holding CAPR

As of 2025 Q4 — sorted by position size

DG Capital Management, LLC 3Y 7Y 5.24% SB Capital Management Inc 4.23% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 2.42% SUPERSTRING CAPITAL MANAGEMENT LP 1.49% Ikarian Capital, LLC 3Y 1.3% MOODY ALDRICH PARTNERS LLC 3Y 7Y 1.12% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.06% Palo Alto Investors LP 3Y 7Y 0.91% Soleus Capital Management, L.P. 3Y 0.69% Persistent Asset Partners Ltd 0.67%
← Back to XTX Topco Ltd Holdings